Company intelligence / Profile preview

HOMVIORA

Munich, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

Homviora is a long-established German pharmaceutical company specializing in the development and manufacture of natural and homeopathic medicines. Founded in 1937, the company focuses on high-quality herbal preparations and complex homeopathic remedies for chronic conditions such as hypertension, rheumatic diseases, and metabolic disorders. Their flagship product, Homviotensin, is a widely recognized natural treatment for high blood pressure. Homviora combines traditional medicinal knowledge with modern pharmaceutical standards to provide evidence-based natural therapies to patients globally.

Therapeutic areas: PsychiatryCardiovascularNeurologyRheumatologyMen's Health
Modalities: Small moleculePlant extractHerbal medicine
Industry: Biotech

Beyond the preview

Go deeper on HOMVIORA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HOMVIORA.

Explore the full profile